Hazte socio de la SAMFyC

Última publicación SAMFyC: Actualización en MF y APS

 

AULA VIRTUAL SAMFyC

Aula de formación virtual de SAMFyC

SAMFyC CONGRESOS

Historico de Comunicaciones
presentadas a los Congresos
Andaluces de MFyC (SAMFyC), desde 2008.


* * * * * * * * * * * * * * * * * * * * * * * * *

Información Socios

Ofertas de Trabajo
Ofertas de Trabajo SOCIOS SAMFYC

¡Actualiza tus datos!
Actualiza tus datos

 

Buscador de Contenidos

Sociedades Federadas

Medicina Familiar y Comunitaria

Sociedades Científicas de Medicina Familiar y Comunitaria

Enlaces de Interés

Consulte Nuestros Enlaces.
Enlaces de Interés

Acceso Socios



Buscador de publicaciones externas y alertas bibliográficas

Enero 2014 PDF Imprimir E-mail
Escrito por Administrador General de SAMFyC   
Miércoles, 05 de Febrero de 2014 00:00

<< Volver

SELECCIÓN DE REFERENCIAS BIBLIOGRÁFICAS DE LO PUBLICADO EN RELACIÓN CON ATENCIÓN PRIMARIA

Selección realizada por Antonio Manteca González

 

 

ANNALS OF INTERNAL MEDICINE

 

Salas-Salvadó J, Bulló M, Estruch R, Ros E, Covas MI, Ibarrola-Jurado N et al. Prevention of diabetes with mediterranean diets: a subgroup analysis of a randomized trial. Ann Intern Med. 2014; 160:1-10 [EC,I]

                               R/C

PREVENCIÓN DE LA DIABETES CON DIETAS MEDITERRÁNEAS: ANÁLISIS DE SUBGRUPO DE UN ENSAYO ALEATORIZADO

 

Wilson JF. Stable ischemic heart disease. Ann Intern Med. 2014; 160:ITC1-1 [AO,I]

                               R/C

CARDIOPATÍA ISQUÉMICA ESTABLE

 

Moyer VA. Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013 [Epub ahead of print] [M,II]

24276469             R/C

CRIBAJE DEL CÁNCER ORAL: DECLARACIÓN DE RECOMENDACIÓN DEL US PREVENTIVE SERVICES TASK FORCE

 

Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2013 [Epub ahead of print] [M,II]

24217469             R/C

PRESCRIPCIÓN DE OPIOIDES: REVISIÓN SISTEMÁTICA Y VALORACIÓN CRÍTICA DE LAS GUÍAS PARA EL DOLOR CRÓNICO

 

ARTHRITIS AND RHEUMATISM

 

Bruderer S, Bodmer M, Jick SS, Meier CR. Use of diuretics and risk of incident gout: a population-based case-control study. Arthritis Rheumatol. 2014; 66:185-196 [CC,II]

24449584             R/C

USO DE DIURÉTICOS Y RIESGO DE INCIDENCIA DE GOTA: ESTUDIO CASO-CONTROL POBLACIONAL

 

ATENCION PRIMARIA

 

Lobos JM, Polo J, Vargas D. El médico de familia ante las barreras en la prescripción de los nuevos anticoagulantes orales: heterogeneidad, inequidad y confusión. Posicionamiento de las Sociedades Científicas de Atención Primaria en España. Aten Primaria. 2014; 46:1-3 [AO,II]

24268612

EL MÉDICO DE FAMILIA ANTE LAS BARRERAS EN LA PRESCRIPCIÓN DE LOS NUEVOS ANTICOAGULANTES ORALES: HETEROGENEIDAD, INEQUIDAD Y CONFUSIÓN. POSICIONAMIENTO DE LAS SOCIEDADES CIENTÍFICAS DE ATENCIÓN PRIMARIA EN ESPAÑA

 

Leon-Sanromà M, Mínguez J, Cerecedo MJ, Téllez J. ¿Nos pasamos al DSM-5? Un debate con implicaciones clínicas, sociales y económicas. Aten Primaria. 2014; 46:4-5 [AO,I]

24355582

¿NOS PASAMOS AL DSM-5? UN DEBATE CON IMPLICACIONES CLÍNICAS, SOCIALES Y ECONÓMICAS

 

Catalán-Ramos A, Verdú JM, Grau M, Iglesias-Rodal M, Del Val JL, Consola A, et al; @GPC-ICS Group. Prevalencia y control de factores de riesgo cardiovascular en la población general: ¿qué nos dice la historia clínica electrónica? Aten Primaria. 2014; 46:15-24 [T,I]

24325864             R/C

PREVALENCIA Y CONTROL DE FACTORES DE RIESGO CARDIOVASCULAR EN LA POBLACIÓN GENERAL: ¿QUÉ NOS DICE LA HISTORIA CLÍNICA ELECTRÓNICA?

 

Hernández-Díaz J, Paredes-Carbonell JJ, Marín R. Cómo diseñar talleres para promover la salud en grupos comunitarios. Aten Primaria. 2014; 46:40-47 [R,II]

24280035             R/C

CÓMO DISEÑAR TALLERES PARA PROMOVER LA SALUD EN GRUPOS COMUNITARIOS

 

BRITISH MEDICAL JOURNAL

 

Threapleton DE, Greenwood DC, Evans CE, Cleghorn CL, Nykjaer C, Woodhead C, et al. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2013; 347:f6879 [M,II]

24355537             R/C

INGESTA DE FIBRA DIETÉTICA Y RIESGO DE ENFERMEDAD CARDIOVASCULAR: REVISIÓN SISTEMÁTICA Y METAANÁLISIS

 

Grigoriadis S, Vonderporten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, et al. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ. 2014; 348:f6932 [M,II]

24429387             R/C

EXPOSICIÓN PRENATAL A LOS ANTIDEPRESIVOS E HIPERTENSIÓN PULMONAR PERSISTENTE DEL RECIÉN NACIDO: REVISIÓN SISTEMÁTICA Y METAANÁLISIS

 

George J, Majeed W, Mackenzie IS, Macdonald TM, Wei L. Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study. BMJ. 2013; 347:f6954 [CC,II]

24284017             R/C

ASOCIACIÓN ENTRE ACONTECIMIENTOS CARDIOVASCULARES Y FÁRMACOS SOLUBLES, EFERVESCENTES Y DISPERSABLES QUE CONTIENEN SODIO: ESTUDIO CASO-CONTROL ANIDADO

 

Downie A, Williams CM, Henschke N, Hancock MJ, Ostelo RW, de Vet HC, et al. Red flags to screen for malignancy and fracture in patients with low back pain: systematic review. BMJ. 2013; 347:f7095 [M,II]

24335669             R/C

FRACTURAS Y BANDERAS ROJAS PARA CRIBAR MALIGNIDAD EN PACIENTES CON LUMBALGIA: REVISIÓN SISTEMÁTICA

 

Strazzullo P. Sodium in drugs and hypertension. BMJ. 2013; 347:f7321 [AO,I]

24326889

SODIO EN FÁRMACOS E HIPERTENSIÓN

 

Kalso E, Aldington DJ, Moore RA. Drugs for neuropathic pain. BMJ. 2013; 347:f7339 [R,I]

24355386

FÁRMACOS PARA EL DOLOR NEUROPÁTICO

 

Sorita A, Ahmed A, Starr SR, Thompson KM, Reed DA, Prokop L, et al. Off-hour presentation and outcomes in patients with acute myocardial infarction: systematic review and meta-analysis. BMJ. 2014; 348:f7393 [M,II]

24452368             R/C

PRESENTACIÓN FUERA DE HORARIO REGULAR Y RESULTADOS EN PACIENTES CON INFARTO AGUDO DE MIOCARDIO: REVISIÓN SISTEMÁTICA Y METAANÁLISIS

 

Baron RB. Eat more fibre. BMJ. 2013; 347:f7401 [AO,I]

24355540

COMA MÁS FIBRA

 

Cesaroni G, Forastiere F, Stafoggia M, Andersen ZJ, Badaloni C, Beelen R, et al. Long term exposure to ambient air pollution and incidence of acute coronary events: prospective cohort study and meta-analysis in 11 European cohorts from the ESCAPE Project. BMJ. 2014; 348:f7412 [M,II]

24452269             R/C

EXPOSICIÓN A LA CONTAMINACIÓN AMBIENTAL A LARGO PLAZO E INCIDENCIA DE ACONTECIMIENTOS CORONARIOS AGUDOS: ESTUDIO DE COHORTE PROSPECTIVA Y METAANÁLISIS EN 11 COHORTES EUROPEAS DEL PROYECTO ESCAPE

 

Underwood M, Buchbinder R. Red flags for back pain. BMJ. 2013; 347:f7432 [AO,I]

24336004

BANDERAS ROJAS EN LA LUMBALGIA

 

Zwar NA, Mendelsohn CP, Richmond RL. Supporting smoking cessation. BMJ. 2014; 348:f7535 [R,I]

24423971

AYUDA PARA DEJAR DE FUMAR

 

Horgan D, Byrne D, Brand A. EU directive on patients' rights to cross border healthcare. BMJ. 2013; 347:f7694 [AO,I]

24381238

DIRECTIVA DE LA UE SOBRE LOS DERECHOS DE LOS PACIENTES A LA ATENCIÓN SANITARIA AL CRUZAR LA FRONTERA

 

Lapointe-Shaw L, Bell CM. Acute myocardial infarction. BMJ. 2014; 348:f7696 [AO,I]

24452407

INFARTO AGUDO DE MIOCARDIO

 

Graham J, Kirkbride P, Cann K, Hasler E, Prettyjohns M. Prostate cancer: summary of updated NICE guidance. BMJ. 2014; 348:f7524 [M,II]

24401467

CÁNCER DE PRÓSTATA: RESUMEN DE LA GUÍA NICE ACTUALIZADA

 

Abel KM, Heuvelman HP, Jörgensen L, Magnusson C, Wicks S, Susser E, et al. Severe bereavement stress during the prenatal and childhood periods and risk of psychosis in later life: population based cohort study. BMJ. 2014; 348:f7679 [S,II]

24449616             R/C

ESTRÉS GRAVE POR PÉRDIDA DURANTE LOS PERIODOS PRENATAL E INFANTIL Y RIESGO DE PSICOSIS EN LA VIDA POSTERIOR: ESTUDIO DE COHORTE POBLACIONAL

 

Hodgkinson S, Pollit V, Sharpin C, Lecky F; Guideline Development Group. Early management of head injury: summary of updated NICE guidance. BMJ. 2014; 348:g104 [M,II]

24452622

MANEJO PRECOZ DE LAS HERIDAS EN LA CABEZA: RESUMEN DE LA GUÍA NICE ACTUALIZADA

 

Elfström KM, Smelov V, Johansson AL, Eklund C, Nauclér P, Arnheim-Dahlström L, et al. Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial. BMJ. 2014; 348:g130 [EC,II]

24435414             R/C

DURACIÓN A LARGO PLAZO DEL EFECTO PROTECTOR EN MUJERES VPH NEGATIVAS: ENSAYO CONTROLADO ALEATORIZADO DE SEGUIMIENTO DEL CRIBAJE PRIMARIO DE VPH

 

Smith R, Gøtzsche PC, Groves T. Should journals stop publishing research funded by the drug industry? BMJ. 2014; 348:g171 [AO,I]

24423895

¿DEBERÍAN DEJAR DE PUBLICAR LAS REVISTAS INVESTIGACIONES FINANCIADAS POR LA INDUSTRIA FARMACÉUTICA?

 

BRITISH JOURNAL OF PSYCHIATRY

 

Koelen JA, Houtveen JH, Abbass A, Luyten P, Eurelings-Bontekoe EH, Van Broeckhuysen-Kloth SA, et al. Effectiveness of psychotherapy for severe somatoform disorder: meta-analysis. Br J Psychiatry. 2014; 204:12-19 [M,II]

24385460             R/C

EFECTIVIDAD DE LA PSICOTERAPIA EN EL TRASTORNO SOMATOMORFO GRAVE: METAANÁLISIS

 

Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry. 2014; 204:20-29 [M,II]

24385461             R/C

TERAPIA COGNITIVO-CONDUCTUAL PARA LOS SÍNTOMAS DE LA ESQUIZOFRENIA: REVISIÓN SISTEMÁTICA Y METAANÁLISIS CON EXAMEN DE SESGO POTENCIAL

 

CANADIAN MEDICAL ASSOCIATION JOURNAL

 

Reid RD, McDonnell LA, Riley DL, Mark AE, Mosca L, Beaton L, et al. Effect of an intervention to improve the cardiovascular health of family members of patients with coronary artery disease: a randomized trial. CMAJ. 2014; 186:23-30 [EC,I]

24246588             R/C

EFECTO DE UNA INTERVENCIÓN PARA MEJORAR LA SALUD CARDIOVASCULAR DE LOS FAMILIARES DE PACIENTES CON ENFERMEDAD ARTERIAL CORONARIA: ENSAYO ALEATORIZADO

 

El Shayeb M, Topfer LA, Stafinski T, Pawluk L, Menon D. Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis. CMAJ. 2014; 186:E25-E51 [M,II]

24218531             R/C

EXACTITUD DIAGNÓSTICA DE LAS PRUEBAS DE SUEÑO PORTÁTILES NIVEL 3 FRENTE A LA POLISOMNOGRAFÍA NIVEL 1 EN LOS TRASTORNOS RESPIRATORIOS DEL SUEÑO: REVISIÓN SISTEMÁTICA Y METAANÁLISIS

 

Stall N, Wong CL. Hospital-acquired delirium in older adults. CMAJ. 2014; 186:E61 [AO,I]

24003094

SÍNDROME CONFUSIONAL ADQUIRIDO EN HOSPITAL EN ANCIANOS

 

CIRCULATION

 

Samet JM. Smoking cessation: benefits versus risks of using pharmacotherapy to quit. Circulation. 2014; 129:8-10 [AO,I]

24323794

ABANDONO TABÁQUICO: BENEFICIOS FRENTE A RIESGOS DE USAR FARMACOTERAPIA PARA DEJARLO

 

Mills EJ, Thorlund K, Eapen S, Wu P, Prochaska JJ. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation. 2014; 129:28-41 [M,II]

24323793             R/C

ACONTECIMIENTOS CARDIOVASCULARES ASOCIADOS CON LAS FARMACOTERAPIAS PARA DEJAR DE FUMAR: METAANÁLISIS EN RED

 

Alcántara C, Davidson KW. Mental disorders and coronary heart disease risk: could the evidence elude us while we sleep? Circulation. 2014; 129:139-141 [AO,I]

24190956

TRASTORNOS MENTALES Y RIESGO DE ENFERMEDAD CORONARIA: ¿PUEDE ESQUIVARNOS LA EVIDENCIA MIENTRAS DORMIMOS?

 

Kuklina EV. Breastfeeding and cardiometabolic profile in childhood: how infant feeding, preterm birth, socioeconomic status, and obesity may fit into the puzzle. Circulation. 2014; 129:281-284 [AO,I]

24300436

LACTANCIA MATERNA Y PERFIL CARDIOMETABÓLICO EN LA NIÑEZ: CÓMO LA ALIMENTACIÓN INFANTIL, EL NACIMIENTO PREMATURO, EL ESTATUS SOCIOECONÓMICO Y LA OBESIDAD PUEDEN ENCAJAR EN EL PUZZLE

 

Lee CW, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, et al. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial. Circulation. 2014; 129:304-312 [EC,II]

24097439             R/C

DURACIÓN ÓPTIMA DE LA TERAPIA ANTIPLAQUETARIA DUAL TRAS LA IMPLANTACIÓN DE STENT FARMACOACTIVO: ENSAYO CONTROLADO ALEATORIZADO

 

Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014; 129:399-410 [T,II]

24446411

RESUMEN EJECUTIVO: ESTADÍSTICAS DE ENFERMEDAD CARDIACA  E ICTUS-ACTUALIZACIÓN 2014: INFORME DE LA AHA

 

Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014; 129:e28-e292 [T,II]

24352519

ESTADÍSTICAS DE ENFERMEDAD CARDIACA  E ICTUS-ACTUALIZACIÓN 2014: INFORME DE LA AHA

 

DIABETES CARE

 

Cefalu WT, Ratner RE. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: the "gift" that keeps on giving! Diabetes Care. 2014; 37:5-7 [AO,II]

24356590

EL ENSAYO CONTROL DE LA DIABETES Y COMPLICACIONES/ESTUDIO DE EPIDEMIOLOGÍA DE LAS INTERVENCIONES Y COMPLICACIONES DE LA DIABETES A LOS 30 AÑOS: ¡EL "REGALO" QUE NOS SIGUE DANDO!

 

Nathan DM; DCCT/EDIC Research Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014; 37:9-16 [EC,II]

24356592             R/C

EL ENSAYO CONTROL DE LA DIABETES Y COMPLICACIONES/ESTUDIO DE EPIDEMIOLOGÍA DE LAS INTERVENCIONES Y COMPLICACIONES DE LA DIABETES A LOS 30 AÑOS: PANORAMA

 

Aiello LP; DCCT/EDIC Research Group. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014; 37:17-23 [EC,II]

24356593             R/C

RETINOPATÍA DIABÉTICA Y OTROS HALLAZGOS OCULARES EN EL ENSAYO CONTROL DE LA DIABETES Y COMPLICACIONES/ESTUDIO DE EPIDEMIOLOGÍA DE LAS INTERVENCIONES Y COMPLICACIONES DE LA DIABETES

 

de Boer IH; DCCT/EDIC Research Group. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014; 37:24-30 [EC,II]

24356594             R/C

ENFERMEDAD RENAL Y HALLAZGOS RELACIONADOS EN EL ENSAYO CONTROL DE LA DIABETES Y COMPLICACIONES/ESTUDIO DE EPIDEMIOLOGÍA DE LAS INTERVENCIONES Y COMPLICACIONES DE LA DIABETES

 

Lachin JM, Orchard TJ, Nathan DM; DCCT/EDIC Research Group. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014; 37:39-43 [EC,II]

24356596             R/C

ACTUALIZACIÓN SOBRE LOS RESULTADOS CARDIOVASCULARES A LOS 30 AÑOS DEL ENSAYO CONTROL DE LA DIABETES Y COMPLICACIONES/ESTUDIO DE EPIDEMIOLOGÍA DE LAS INTERVENCIONES Y COMPLICACIONES DE LA DIABETES

 

Gubitosi-Klug RA; DCCT/EDIC Research Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions. Diabetes Care. 2014; 37:44-49 [EC,II]

24356597             R/C

EL ENSAYO CONTROL DE LA DIABETES Y COMPLICACIONES/ESTUDIO DE EPIDEMIOLOGÍA DE LAS INTERVENCIONES Y COMPLICACIONES DE LA DIABETES A LOS 30 AÑOS: RESUMEN Y DIRECCIONES FUTURAS

 

Summary of revisions to the 2014 clinical practice recommendations. Diabetes Care. 2014; 37 Suppl 1:S4 [M,III]

24357213

RESUMEN DE REVISIONES PARA LAS RECOMENDACIONES DE PRÁCTICA CLÍNICA DE 2014

 

Executive summary: standards of medical care in diabetes--2014. Diabetes Care. 2014; 37 Suppl 1:S5-S13 [M,III]

24357214

RESUMEN EJECUTIVO: ESTÁNDARES DE ATENCIÓN MÉDICA EN DIABETES--2014

 

American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care. 2014; 37 Suppl 1:S14-S80 [M,III]

24357209

ESTÁNDARES DE ATENCIÓN MÉDICA EN DIABETES--2014

 

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014; 37 Suppl 1:S81-S90 [M,III]

24357215

DIAGNÓSTICO Y CLASIFICACIÓN DE LA DIABETES MELLITUS

 

Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2014; 37 Suppl 1:S120-S143 [M,III]

24357208

RECOMENDACIONES EN TERAPIA NUTRICIONAL PARA EL MANEJO DE ADULTOS CON DIABETES

 

Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, et al; 2012 Standards Revision Task Force. National standards for diabetes self-management education and support. Diabetes Care. 2014; 37 Suppl 1:S144-S153 [M,II]

24357210

ESTÁNDARES NACIONALES PARA LA FORMACIÓN Y APOYO EN EL AUTOMANEJO DE LA DIABETES

 

EUROPEAN HEART JOURNAL

 

Troughton R, Felker GM, Januzzi JL Jr. Natriuretic peptide-guided heart failure management. Eur Heart J. 2014; 35:16-24 [R,I]

24216390             R/C

MANEJO DE LA INSUFICIENCIA CARDIACA GUIADO POR EL PÉPTIDO NATRIURÉTICO

 

Bartel T, Müller S, Biviano A, Hahn RT. Why is intracardiac echocardiography helpful? Benefits, costs, and how to learn. Eur Heart J. 2014; 35:69-76 [R,I]

24144789             R/C

¿POR QUÉ  ES  DE UTILIDAD LA ECOCARDIOGRAFÍA INTRACARDIACA? BENEFICIOS, COSTES Y CÓMO APRENDERLA

 

Aro AL, Anttonen O, Kerola T, Junttila MJ, Tikkanen JT, Rissanen HA, et al. Prognostic significance of prolonged PR interval in the general population. Eur Heart J. 2014; 35:123-129 [S,I]

23677846             R/C

SIGNIFICANCIA PRONÓSTICA DEL INTERVALO PR PROLONGADO EN LA POBLACIÓN GENERAL

 

FAMILY MEDICINE

 

Scherger JE. The unfinished story of family medicine transformation. Fam Med. 2014; 46:5-6 [AO,I]

24415501

LA HISTORIA INACABADA DE LA TRANSFORMACIÓN DE LA MEDICINA DE FAMILIA

 

Baird MA. Primary care in the age of reform-not a time for complacency. Fam Med. 2014; 46:7-10 [AO,I]

24415502             R/C

ATENCIÓN PRIMARIA EN LA ERA DE LA REFORMA-NO ES HORA PARA LA COMPLACENCIA

 

Manson HM, Satin D, Nelson V, Vadiveloo T. Ethics education in family medicine training in the United States: a national survey. Fam Med. 2014; 46:28-35 [T,I]

24415505             R/C

FORMACIÓN EN ÉTICA EN LA ENSEÑANZA DE LA MEDICINA DE FAMILIA EN LOS ESTADOS UNIDOS: ENCUESTA NACIONAL

 

GACETA SANITARIA

 

Rodríguez-Salés V, Roura E, Ibáñez R, Peris M, Bosch FX, Coma EE, et al. Cobertura del cribado de cáncer de cuello uterino en Cataluña (2008-2011) Gac Sanit. 2014; 28:7-13 [T,I]

23916983             R/C

COBERTURA DEL CRIBADO DE CÁNCER DE CUELLO UTERINO EN CATALUÑA (2008-2011)

 

García-Garrido AB, Vázquez-Rodríguez JA, Grande-González E, Ramos-Barrón MÁ. Cobertura y costes del cribado oportunista de detección precoz del cáncer de cuello uterino en Cantabria. Gac Sanit. 2014; 28:14-19 [T,I]

23845269             R/C

COBERTURA Y COSTES DEL CRIBADO OPORTUNISTA DE DETECCIÓN PRECOZ DEL CÁNCER DE CUELLO UTERINO EN CANTABRIA

 

Ariza C, García-Continente X, Villalbí JR, Sánchez-Martínez F, Pérez A, Nebot M. Consumo de tabaco de los adolescentes en Barcelona y tendencias a lo largo de 20 años. Gac Sanit. 2014; 28:25-33 [T,I]

24332818             R/C

CONSUMO DE TABACO DE LOS ADOLESCENTES EN BARCELONA Y TENDENCIAS A LO LARGO DE 20 AÑOS

 

Aguilar-Palacio I, Carrera-Lasfuentes P, Poblador-Plou B, Prados-Torres A, Rabanaque-Hernández MJ; por el Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA). Morbilidad y consumo de fármacos. Comparación de resultados entre la Encuesta Nacional de Salud y los registros electrónicos. Gac Sanit. 2014; 28:41-47 [T,II]

23680136             R/C

MORBILIDAD Y CONSUMO DE FÁRMACOS. COMPARACIÓN DE RESULTADOS ENTRE LA ENCUESTA NACIONAL DE SALUD Y LOS REGISTROS ELECTRÓNICOS

 

López-Sobaler AM, Ortega RM. Cuestionando la efectividad de los impuestos a alimentos como medida de lucha frente a la obesidad. Gac Sanit. 2014; 28:69-71 [AO,I]

24360617

CUESTIONANDO LA EFECTIVIDAD DE LOS IMPUESTOS A ALIMENTOS COMO MEDIDA DE LUCHA FRENTE A LA OBESIDAD

 

Quiles-Izquierdo J. Un dulce impuesto para no amargar la salud. Gac Sanit. 2014; 28:72-73 [AO,I]

24360616

UN DULCE IMPUESTO PARA NO AMARGAR LA SALUD

 

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

 

Frieden TR, King SM, Wright JS. Protocol-based treatment of hypertension: a critical step on the pathway to progress. JAMA. 2014; 311:21-22 [AO,I]

24231925

TRATAMIENTO DE LA HIPERTENSIÓN MEDIANTE PROTOCOLO: UN PASO CRÍTICO EN EL SENDERO HACIA EL PROGRESO

 

Jensen MD, Ryan DH. New obesity guidelines: promise and potential. JAMA. 2014; 311:23-24 [AO,I]

24381963

NUEVAS GUÍAS PARA LA OBESIDAD: PROMESA Y POTENCIAL

 

Evans DA, Morris MC, Rajan KB. Vitamin E, memantine, and Alzheimer disease. JAMA. 2014; 311:29-30 [AO,I]

24381966

VITAMINA E, MEMANTINA Y ENFERMEDAD DE ALZHEIMER

 

Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014; 311:33-44 [EC,I]

24381967             R/C

EFECTO DE LA VITAMINA E Y LA MEMANTINA SOBRE EL DECLIVE FUNCIONAL EN LA ENFERMEDAD DE ALZHEIMER: ENSAYO ALEATORIZADO COOPERATIVO TEAM-ADVA

 

Rubertsson S, Lindgren E, Smekal D, Östlund O, Silfverstolpe J, Lichtveld RA, et al. Mechanical chest compressions and simultaneous defibrillation vs conventional cardiopulmonary resuscitation in out-of-hospital cardiac arrest: the LINC randomized trial. JAMA. 2014; 311:53-61 [EC,I]

24240611             R/C

COMPRESIONES MECÁNICAS TORÁCICAS Y DESFIBRILACIÓN SIMULTÁNEA FRENTE A REANIMACIÓN CARDIOPULMONAR CONVENCIONAL EN LA PARADA CARDIACA EXTRAHOSPITALARIA: ENSAYO ALEATORIZADO LINC

 

Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA. 2014; 311:74-86 [M,I]

24231879             R/C

TRATAMIENTO FARMACOLÓGICO A LARGO PLAZO PARA LA OBESIDAD: REVISIÓN SISTEMÁTICA Y CLÍNICA

 

Cole HM, Fiore MC. The war against tobacco: 50 years and counting. JAMA. 2014; 311:131-132 [AO,I]

24399546

LA GUERRA CONTRA EL TABACO: 50 AÑOS Y CONTANDO

 

Abrams DB. Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete? JAMA. 2014; 311:135-136 [AO,I]

24399548

PROMESA Y PELIGRO DE LOS CIGARRILLOS ELECTRÓNICOS: ¿PUEDE LA TECNOLOGÍA DISRUPTIVA HACER OBSOLETOS  LOS CIGARRILLOS?

 

Evins AE, Cather C, Pratt SA, Pachas GN, Hoeppner SS, Goff DC, et al. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA. 2014; 311:145-154 [EC,I]

24399553             R/C

TRATAMIENTO DE MANTENIMIENTO CON VARENICILINA EN EL ABANDONO TABÁQUICO EN PACIENTES CON ESQUIZOFRENIA Y TRASTORNO BIPOLAR: ENSAYO CLÍNICO ALEATORIZADO

 

Ebbert JO, Hatsukami DK, Croghan IT, Schroeder DR, Allen SS, Hays JT, et al. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. JAMA. 2014; 311:155-163 [EC,I]

24399554             R/C

COMBINACIÓN DE VARENICILINA Y BUPROPIÓN PARA LA DEPENDENCIA TABÁQUICA EN FUMADORES DE CIGARRILLOS: ENSAYO ALEATORIZADO

 

Holford TR, Meza R, Warner KE, Meernik C, Jeon J, Moolgavkar SH, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA. 2014; 311:164-171 [T,II]

24399555             R/C

CONTROL DEL TABACO Y REDUCCIÓN DE LAS MUERTES PREMATURAS RELACIONADAS CON EL FUMAR EN LOS ESTADOS UNIDOS, 1964-2012

 

Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA. 2014; 311:172-182 [T,I]

24399556             R/C

TENDENCIAS EN EL TABAQUISMO ENTRE ADULTOS CON ENFERMEDAD MENTAL Y ASOCIACIÓN ENTRE TRATAMIENTO DE SALUD MENTAL Y ABANDONO TABÁQUICO

 

Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA. 2014; 311:183-192 [T,II]

24399557             R/C

PREVALENCIA DEL TABAQUISMO Y CONSUMO DE CIGARRILLOS EN 187 PAÍSES, 1980-2012

 

Cahill K, Stevens S, Lancaster T. Pharmacological treatments for smoking cessation. JAMA. 2014; 311:193-194 [AO,II]

24399558             R/C

TRATAMIENTOS FARMACOLÓGICOS PARA EL ABANDONO DEL TABAQUISMO

 

Sarna L, Bialous SA, Nandy K, Antonio AL, Yang Q. Changes in smoking prevalences among health care professionals from 2003 to 2010-2011. JAMA. 2014; 311:197-199 [AO,I]

24399560

CAMBIOS EN LAS PREVALENCIAS DE TABAQUISMO ENTRE LOS PROFESIONALES DE LA ATENCIÓN SANITARIA DESDE 2003 A 2010-2011

 

Greenland P. More evidence for coronary calcium as a measure of cardiovascular risk: has anything changed? JAMA. 2014; 311:247-248 [AO,I]

24247361

MÁS PRUEBAS DEL CALCIO CORONARIO COMO MEDIDA DEL RIESGO CARDIOVASCULAR: ¿HA CAMBIADO ALGO?

 

Criqui MH, Denenberg JO, Ix JH, McClelland RL, Wassel CL, Rifkin DE, et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA. 2014; 311:271-278 [T,I]

24247483             R/C

DENSIDAD DE CALCIO DE LA PLACA ARTERIAL CORONARIA Y RIESGO DE INCIDENCIA DE ACONTECIMIENTOS CARDIOVASCULARES

 

Morris AM, Regenbogen SE, Hardiman KM, Hendren S. Sigmoid diverticulitis: a systematic review. JAMA. 2014; 311:287-297 [M,II]

24430321             R/C

DIVERTICULITIS SIGMOIDEA: REVISIÓN SISTEMÁTICA

 

Buchsbaum DJ, Croce CM. Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer? JAMA. 2014; 311:363-365 [AO,I]

24449314

¿MEJORARÁ LA DETECCIÓN EN SANGRE DE BIOMARCADORES DE MICRO-RNA EL DIAGNÓSTICO Y LA SUPERVIVENCIA DE LOS PACIENTES CON CÁNCER PANCREÁTICO?

 

Smith R, Rennie D. Evidence-based medicine--an oral history. JAMA. 2014; 311:365-367 [AO,I]

24449049

MEDICINA BASADA EN LA EVIDENCIA--HISTORIA ORAL

 

Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA. 2014; 311:392-404. [CC,I]

24449318             R/C

BIOMARCADORES DE MICRO-RNA EN SANGRE TOTAL PARA LA DETECCIÓN DEL CÁNCER PANCREÁTICO

 

Ruiz-Canela M, Estruch R, Corella D, Salas-Salvadó J, Martínez-González MA. Association of Mediterranean diet with peripheral artery disease: the PREDIMED randomized trial. JAMA. 2014; 311:415-417 [EC,I]

24449321

ASOCIACIÓN DE DIETA MEDITERRÁNEA CON ENFERMEDAD ARTERIAL PERIFÉRICA: ENSAYO ALEATORIZADO PREDIMED

 

JAMA INTERNAL MEDICINE

 

Dukes JW, Marcus GM. Atrial fibrillation begets myocardial infarction. JAMA Intern Med. 2014; 174:5-7 [AO,I]

24190287             R/C

LA FIBRILACIÓN AURICULAR GENERA INFARTO DE MIOCARDIO

 

Lieberman D. Screening for colorectal cancer in individuals at average risk: current methods and emerging issues. JAMA Intern Med. 2014; 174:10-11 [AO,I]

24145734

CRIBAJE DEL CÁNCER COLORRECTAL EN INDIVIDUOS DE RIESGO PROMEDIO: MÉTODOS ACTUALES Y ASPECTOS EMERGENTES

 

Thomsen M, Nordestgaard BG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. JAMA Intern Med. 2014; 174:15-22 [T,I]

24217719             R/C

INFARTO DE MIOCARDIO Y CARDIOPATÍA ISQUÉMICA EN LA OBESIDAD Y EL SOBREPESO CON Y SIN SÍNDROME METABÓLICO

 

Taylor PN, Iqbal A, Minassian C, Sayers A, Draman MS, Greenwood R, et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 2014; 174:32-39 [S,I]

24100714             R/C

DESCENSO DEL UMBRAL PARA TRATAR LOS NIVELES DE TIROTROPINA ELEVADOS LIMÍTROFES-EQUILIBRAR BENEFICIOS Y RIESGOS: EVIDENCIA A PARTIR DE UN ESTUDIO COMUNITARIO DE GRAN DIMENSIÓN

 

Than M, Aldous S, Lord SJ, Goodacre S, Frampton CM, Troughton R, et al. A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial. JAMA Intern Med. 2014; 174:51-58 [EC,I]

24100783             R/C

PROTOCOLO DIAGNÓSTICO DE 2 HORAS PARA DOLOR TORÁCICO DE POSIBLE ORIGEN CARDIACO EN EL DEPARTAMENTO DE URGENCIAS: ENSAYO CLÍNICO ALEATORIZADO

 

Mason BJ, Quello S, Goodell V, Shadan F, Kyle M, Begovic A. Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Intern Med. 2014; 174:70-77 [EC,I]

24190578             R/C

TRATAMIENTO CON GABAPENTINA PARA LA DEPENDENCIA DEL ALCOHOL: ENSAYO CLÍNICO ALEATORIZADO

 

Rillamas-Sun E, Lacroix AZ, Waring ME, Kroenke CH, Lamonte MJ, Vitolins MZ, et al. Obesity and late-age survival without major disease or disability in older women. JAMA Intern Med. 2014; 174:98-106 [S,II]

24217806             R/C

OBESIDAD Y SUPERVIVENCIA TARDÍA SIN ENFERMEDAD GRAVE NI DISCAPACIDAD EN MUJERES MAYORES

 

Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014; 174:107-114 [S,II]

24190540             R/C

FIBRILACIÓN AURICULAR Y RIESGO DE INFARTO DE MIOCARDIO

 

JAMA PSYCHIATRY

 

Joshi PT. Mental health services for children and adolescents: challenges and opportunities. JAMA Psychiatry. 2014; 71:17-18 [AO,I]

24285293

SERVICIOS DE SALUD MENTAL PARA NIÑOS Y ADOLESCENTES: RETOS Y OPORTUNIDADES

 

Freeman EW, Sammel MD, Boorman DW, Zhang R. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry. 2014; 71:36-43 [S,I]

24227182             R/C

PATRÓN LONGITUDINAL DE SÍNTOMAS DEPRESIVOS EN TORNO A LA MENOPAUSIA NATURAL

 

JOURNAL OF THE AMERICAN BOARD OF FAMILY PHYSICIANS

 

Bowman MA, Neale AV. Family physicians are complex care physicians and quality of care advancement experts. J Am Board Fam Med. 2014; 27:1-3 [AO,I]

24390876             R/C

LOS MÉDICOS DE FAMILIA SON MÉDICOS PARA ATENCIÓN COMPLEJA Y  EXPERTOS EN CALIDAD DE ATENCIÓN AVANZADA

 

Katerndahl D. Providing complex (rather than complicated) chronic care. J Am Board Fam Med. 2014; 27:6-7 [AO,I]

24390878

PROPORCIONAR ATENCIÓN CRÓNICA COMPLEJA (MÁS QUE COMPLICADA)

 

Sharma MA, Cheng N, Moore M, Coffman M, Bazemore AW. Patients with high-cost chronic conditions rely heavily on primary care physicians. J Am Board Fam Med. 2014; 27:11-12 [AO,II]

24390880             R/C

PACIENTES CON ENFERMEDADES CRÓNICAS DE ALTO COSTE CONFÍAN FUERTEMENTE EN LOS MÉDICOS DE ATENCIÓN PRIMARIA

 

Mitchell NS, Manning BK, Staton EW, Emsermann CD, Dickinson LM, Pace WD. Outcomes of biomarker feedback on physical activity, eating habits, and emotional health: from the Americans in Motion-Healthy Intervention (AIM-HI) study. J Am Board Fam Med. 2014; 27:61-69 [EC,I]

24390887             R/C

RESULTADOS DE RETROALIMENTACIÓN MEDIANTE BIOMARCADORES SOBRE ACTIVIDAD FÍSICA, COSTUMBRES ALIMENTARIAS Y SALUD EMOCIONAL: DEL ESTUDIO AIM-HI

 

Terpening C. MALAdaptive: do we avoid metformin unnecessarily? J Am Board Fam Med. 2014; 27:136-141 [AO,II]

24390895             R/C

MALADAPTIVE: ¿EVITAMOS INNECESARIAMENTE LA METFORMINA?

 

MEDICINA CLINICA

 

Arboix A, Massons J, García-Eroles L, Grau-Olivares M, Targa C, Comes E, et al. Variaciones en el perfil clínico y pronóstico de las hemorragias intracerebrales no traumáticas (1986-2004) Med Clin (Barc). 2014; 142:1-6 [S,I]

23768852             R/C

VARIACIONES EN EL PERFIL CLÍNICO Y PRONÓSTICO DE LAS HEMORRAGIAS INTRACEREBRALES NO TRAUMÁTICAS (1986-2004)

 

Royo-Bordonada MÁ, Lobos JM, Brotons C, Villar F, de Pablo C, Armario P, et al; en nombre del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC). El estado de la prevención cardiovascular en España. Med Clin (Barc). 2014; 142:7-14 [T,II]

23433666             R/C

EL ESTADO DE LA PREVENCIÓN CARDIOVASCULAR EN ESPAÑA

 

Sanfélix-Genovés J, Catalá-López F, Sanfélix-Gimeno G, Hurtado I, Baixauli C, Peiró S. Variabilidad en las recomendaciones para el abordaje clínico de la osteoporosis. Med Clin (Barc). 2014; 142:15-22 [R,I]

23332628             R/C

VARIABILIDAD EN LAS RECOMENDACIONES PARA EL ABORDAJE CLÍNICO DE LA OSTEOPOROSIS

 

Jiménez PE. Hemorragias intracerebrales espontáneas: perspectivas actuales. Med Clin (Barc). 2014; 142:23-24 [AO,I]

23790580

HEMORRAGIAS INTRACEREBRALES ESPONTÁNEAS: PERSPECTIVAS ACTUALES

 

Calvet X, Motos J, Villoria A. Cómo redactar un informe médico para la valoración de minusvalía o discapacidad. Med Clin (Barc). 2014; 142:25-28 [R,I]

24216011             R/C

CÓMO REDACTAR UN INFORME MÉDICO PARA LA VALORACIÓN DE MINUSVALÍA O DISCAPACIDAD

 

Sanvisens A, Rivas I, Faure E, Muñoz T, Rubio M, Fuster D, et al. Características de los pacientes adictos a la heroína admitidos en un programa de tratamiento con metadona. Med Clin (Barc). 2014; 142:53-58 [T,I]

23337454             R/C

CARACTERÍSTICAS DE LOS PACIENTES ADICTOS A LA HEROÍNA ADMITIDOS EN UN PROGRAMA DE TRATAMIENTO CON METADONA

 

Sabrià M. Legionelosis en el niño y nuevas fuentes de transmisión. Med Clin (Barc). 2014; 142:67-69 [AO,I]

24029452

LEGIONELOSIS EN EL NIÑO Y NUEVAS FUENTES DE TRANSMISIÓN

 

Arenas-Fernández J, Fernández-Martín JL, Cannata-Andía JB, Martínez-Camblor P. Estudios observacionales: el azar y otros dioses. Med Clin (Barc). 2014; 142:80-84 [AO,I]

23831405

ESTUDIOS OBSERVACIONALES: EL AZAR Y OTROS DIOSES

 

REVISTA ESPAÑOLA DE CARDIOLOGIA

 

García-García C, Molina L, Subirana I, Sala J, Bruguera J, Arós F, et al. Diferencias en función del sexo en las características clínicas, tratamiento y mortalidad a 28 días y 7 años de un primer infarto agudo de miocardio. Estudio RESCATE II. Rev Esp Cardiol. 2014; 67:28-35 [S,I]

24231045             R/C

DIFERENCIAS EN FUNCIÓN DEL SEXO EN LAS CARACTERÍSTICAS CLÍNICAS, TRATAMIENTO Y MORTALIDAD A 28 DÍAS Y 7 AÑOS DE UN PRIMER INFARTO AGUDO DE MIOCARDIO. ESTUDIO RESCATE II

 

THE LANCET

 

Treatment of anorexia nervosa. Lancet. 2014; 383:100 [AO,I]

24411955

TRATAMIENTO DE LA ANOREXIA NERVIOSA

 

Bulik CM. The challenges of treating anorexia nervosa. Lancet. 2014; 383:105-106 [AO,I]

24131860

LOS RETOS DE TRATAR LA ANOREXIA NERVIOSA

 

Paul F, Wattjes MP. Chronic cerebrospinal venous insufficiency in multiple sclerosis: the final curtain. Lancet. 2014; 383:106-108 [AO,I]

24119383

INSUFICIENCIA VENOSA CEREBROESPINAL CRÓNICA EN LA ESCLEROSIS MÚLTIPLE: EL TELÓN FINAL

 

Rosen CJ. Vitamin D supplementation: bones of contention. Lancet. 2014; 383:108-110 [AO,I]

24119979

SUPLEMENTOS DE VITAMINA D: HUESOS DE CONTENCIÓN

 

Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. 2014; 383:146-155 [M,II]

24119980             R/C

EFECTOS DE LOS SUPLEMENTOS DE VITAMINA D SOBRE LA DENSIDAD MINERAL ÓSEA: REVISIÓN SISTEMÁTICA Y METAANÁLISIS

 

Active surveillance for early-stage prostate cancer. Lancet. 2014; 383:188 [AO,I]

24439724

VIGILANCIA ACTIVA PARA EL CÁNCER DE PRÓSTATA EN SU PRIMER ESTADIO

Williams C, House A. Cognitive behaviour therapy for health anxiety. Lancet. 2014; 383:190-191 [AO,I]

24139976

TERAPIA COGNITIVO-CONDUCTUAL PARA LA ANSIEDAD POR LA SALUD

 

Giroud M, Jacquin A, Béjot Y. The worldwide landscape of stroke in the 21st century. Lancet. 2014; 383:195-197 [AO,I]

24449941

EL PAISAJE MUNDIAL DEL ICTUS EN EL SIGLO 21

 

Tyrer P, Cooper S, Salkovskis P, Tyrer H, Crawford M, Byford S, et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial. Lancet. 2014; 383:219-225 [EC,II]

24139977             R/C

RENTABILIDAD ECONÓMICA Y CLÍNICA DE LA TERAPIA COGNITIVO-CONDUCTUAL PARA LA ANSIEDAD POR LA SALUD EN PACIENTES MÉDICOS: ENSAYO CONTROLADO ALEATORIZADO MULTICÉNTRICO

 

Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014; 383:245-254 [M,II]

24449944             R/C

CARGA REGIONAL Y MUNDIAL DE ICTUS DURANTE 1999-2010: HALLAZGOS DEL ESTUDIO 2010 CARGA MUNDIAL DE ENFERMEDAD

 

O'Connell T, Rasanathan K, Chopra M. What does universal health coverage mean? Lancet. 2014; 383:277-279 [AO,II]

23953765

¿QUÉ SIGNIFICA LA COBERTURA SANITARIA UNIVERSAL?

 

THE NEW ENGLAND JOURNAL OF MEDICINE

 

Jones DS. Doctors and the dangers of driving. N Engl J Med. 2014; 370:8-11 [AO,I]

24382063

LOS MÉDICOS Y LOS PELIGROS DE CONDUCIR

 

Klauer SG, Guo F, Simons-Morton BG, Ouimet MC, Lee SE, Dingus TA. Distracted driving and risk of road crashes among novice and experienced drivers. N Engl J Med. 2014; 370:54-59 [T,II]

24382065             R/C

CONDUCCIÓN DISTRAÍDA Y RIESGO DE ACCIDENTES DE TRÁFICO ENTRE CONDUCTORES NOVATOS Y EXPERIMENTADOS

 

Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med. 2014; 370:60-68 [R,I]

24382066

EFECTOS MUNDIALES DEL TABAQUISMO, DE SU ABANDONO Y DE LOS IMPUESTOS SOBRE EL TABACO

 

Yurkiewicz IR, Korf BR, Lehmann LS. Prenatal whole-genome sequencing--is the quest to know a fetus's future ethical? N Engl J Med. 2014; 370:195-197 [AO,I]

24428465

SECUENCIACIÓN DEL GENOMA COMPLETO PRENATAL ¿ES ÉTICA LA INVESTIGACIÓN PARA SABER EL FUTURO DE UN FETO?

 

Tobias DK, Pan A, Jackson CL, O'Reilly EJ, Ding EL, Willett WC, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014; 370:233-244 [S,II]

24428469             R/C

ÍNDICE DE MASA CORPORAL Y MORTALIDAD ENTRE ADULTOS CON DIABETES TIPO 2 DE NUEVA APARICIÓN

 

Iams JD. Clinical practice. Prevention of preterm parturition. N Engl J Med. 2014; 370:254-261 [R,I]

24428470

PREVENCIÓN DEL PARTO PREMATURO

 

Keaney JF Jr, Curfman GD, Jarcho JA. A pragmatic view of the new cholesterol treatment guidelines. N Engl J Med. 2014; 370:275-278 [AO,II]

24283199

VISIÓN PRAGMÁTICA DE LAS NUEVAS GUÍAS PARA EL TRATAMIENTO DEL COLESTEROL

 

THORAX

 

Afzal S, Lange P, Bojesen SE, Freiberg JJ, Nordestgaard BG. Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease. Thorax. 2014; 69:24-31 [S,I]

23908128             R/C

25-HIDROXIVITAMINA D PLASMÁTICA, FUNCIÓN PULMONAR Y RIESGO DE EPOC

 

Durrington HJ, Farrow SN, Loudon AS, Ray DW. The circadian clock and asthma. Thorax. 2014; 69:90-92 [AO,I]

23704227             R/C

RELOJ CIRCADIANO Y ASMA

 

ANNALS OF INTERNAL MEDICINE

 

S24276469 
 The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.

S24217469
Despite limited evidence and variable development methods, recent guidelines on chronic pain agree on several opioid risk mitigation strategies, including upper dosing thresholds; cautions with certain medications; attention to drug-drug and drug-disease interactions; and use of risk assessment tools, treatment agreements, and urine drug testing. Future research should directly examine the effectiveness of opioid risk mitigation strategies.

SALAS
Conclusion: A Mediterranean diet enriched with EVOO but without energy restrictions reduced diabetes risk among persons with high cardiovascular risk.

WILSON
Stable ischemic heart disease (SIHD) affects many millions of Americans, with associated annual costs measured in tens of billions of dollars. It is a leading cause of death in the United States. SIHD occurs when coronary artery disease (CAD) reduces the blood supply to the heart and typically causes recurrent chest pain or pressure known as angina. The angina is exacerbated by activity or stress, lasts for minutes not seconds or hours, and goes away with rest or medication. Timely diagnosis and optimal treatment can reduce complications and mortality from SIHD.

 

ARTHRITIS AND RHEUMATISM

 

S24449584 
 Use of loop diuretics, thiazide diuretics, and thiazide-like diuretics was associated with an increased risk of incident gout, although use of potassium-sparing agents was not.

 

ATENCION PRIMARIA

 

S24280035
Una de las estrategias de promoción de la salud es el desarrollo de habilidades para la vida considerando a las propias personas como principal recurso para la salud. Un taller ha de conseguir que sus participantes se conviertan en «activos» para tomar decisiones y generar salud, centrándose en el desarrollo y adquisición de habilidades en grupo de una manera motivadora y con la finalidad de alcanzar unos objetivos. Los conceptos que fundamentan el diseño de un taller y que han de plantearse como etapa 0 son: planificación participativa, capacitar, aprendizaje significativo, aprender en grupo y técnicas participativas.

Las etapas que se deben seguir para diseñar un taller y facilitar su aplicación son: etapa 0 de fundamentación, etapa inicial, de acogida y de evaluación inicial; etapa central o de construcción del aprendizaje basado en la adquisición de conocimientos, actitudes y habilidades, y etapa final o de evaluación.

S24325864 

Hypertension was the most prevalent cardiovascular risk factor in the Catalan population attended at primary care centers. About two thirds of individuals with hypertension or DM2 were adequately controlled; hypercholesterolemia control was particularly low.

 

BRITISH MEDICAL JOURNAL

 

S24435414 

Over long term follow-up, the cumulative incidence of CIN2+ was the same for HPV screening and for cytology, implying that the increased sensitivity of HPV screening for CIN2+ reflects earlier detection rather than overdiagnosis. The low long term risks of CIN3+ among women who tested negative in HPV screening, support screening intervals of five years for such women.

S24452269 

Long term exposure to particulate matter is associated with incidence of coronary events, and this association persists at levels of exposure below the current European limit values.

S24452368 

This systematic review suggests that patients with acute myocardial infarction presenting during off-hours have higher mortality, and patients with STEMI have longer door to balloon times. Clinical performance measures may need to account for differences arising from time of presentation to a healthcare facility.

S24429387
The risk of persistent pulmonary hypertension of the newborn seems to be increased for infants exposed to SSRIs in late pregnancy, independent of the potential moderator variables examined. A significant relation for exposure to SSRIs in early pregnancy was not evident. Although the statistical association was significant, clinically the absolute risk of persistent pulmonary hypertension of the newborn remained low even in the context of late exposure to SSRIs.

S24335669

While several red flags are endorsed in guidelines to screen for fracture or malignancy, only a small subset of these have evidence that they are indeed informative. These findings suggest a need for revision of many current guidelines.

S24449616 

Postnatal but not prenatal bereavement stress in mothers is associated with an increased risk of psychosis in offspring. Risks are especially high for affective psychosis after suicide in the nuclear family, an effect that is not explained by family psychiatric history. Future studies are needed to understand possible sources of risk and resilience so that structures can be put in place to support vulnerable children and their families.

S24284017 

Exposure to sodium-containing formulations of effervescent, dispersible, and soluble medicines was associated with significantly increased odds of adverse cardiovascular events compared with standard formulations of those same drugs. Sodium-containing formulations should be prescribed with caution only if the perceived benefits outweigh these risks.

S24355537 

Greater dietary fibre intake is associated with a lower risk of both cardiovascular disease and coronary heart disease. Findings are aligned with general recommendations to increase fibre intake. The differing strengths of association by fibre type or source highlight the need for a better understanding of the mode of action of fibre components.

 

BRITISH JOURNAL OF PSYCHIATRY

 

S24385460 

Overall findings suggest that psychotherapy is effective in severe somatoform disorder. Future randomised controlled studies should examine specific interventions and mechanisms of change.

S24385461 

Cognitive-behavioural therapy has a therapeutic effect on schizophrenic symptoms in the 'small' range. This reduces further when sources of bias, particularly masking, are controlled for.

 

CANADIAN MEDICAL ASSOCIATION JOURNAL

 

S24246588 

A health educator-led heart-health intervention did not improve the ratio of total cholesterol to HDL cholesterol but did increase reported physical activity and fruit and vegetable consumption among family members of patients with CAD. Hospitalization of a spouse, sibling or parent is an opportunity to improve cardiovascular health among other family members.

S24218531 

Level 3 portable devices showed good diagnostic performance compared with level 1 sleep tests in adult patients with a high pretest probability of moderate to severe obstructive sleep apnea and no unstable comorbidities. For patients suspected of having other types of sleep-disordered breathing or sleep disorders not related to breathing, level 1 testing remains the reference standard.

 

CIRCULATION

 

S24097439 

Among patients who were on 12-month dual antiplatelet therapy without complications, an additional 24 months of dual antiplatelet therapy versus aspirin alone did not reduce the risk of the composite end point of death from cardiac causes, myocardial infarction, or stroke.

S24323793 

Smoking cessation therapies do not appear to raise the risk of serious cardiovascular disease events.

 

DIABETES CARE

 

S24356597 

With the comprehensive data collection and the remarkable participant retention over 30 years, the DCCT/EDIC continues as an irreplaceable resource for understanding type 1 diabetes and its long-term complications.

S24356592 

DCCT/EDIC has demonstrated the effectiveness of INT in reducing the long-term complications of T1DM and improving the prospects for a healthy life span.

S24356596 

DCCT INT and the attendant 6.5 years of lower HbA1c had long-term salutary effects on the development and progression of atherosclerosis and cardiovascular disease during the subsequent follow-up during EDIC.

S24356593 

INT delays the onset and slows the progression of DR. Furthermore, the early effects of metabolic control continue to accrue over many years despite subsequent comparable glycemic control (metabolic memory). These results emphasize the need for optimizing glycemic control as early as possible in patients with diabetes.

S24356594 

In the DCCT/EDIC, INT resulted in clinically important, durable reductions in the risks of microalbuminuria, macroalbuminuria, impaired GFR, and hypertension.

 

EUROPEAN HEART JOURNAL

 

S23677846 

In the middle-aged general population, prolonged PR interval normalizes in a substantial proportion of subjects during the time course, and it is not associated with an increased risk of all-cause or cardiovascular mortality.

S24144789 

Current interventional procedures in structural heart disease and cardiac arrhythmias require peri-interventional echocardiographic monitoring and guidance to become as safe, expedient, and well-tolerated for patients as possible. Intracardiac echocardiography (ICE) complements and has in part replaced transoesophageal echocardiography (TEE), including real-time three-dimensional (RT-3D) imaging. The latter is still widely accepted as a method to prepare for and to guide interventional treatments. In contrast to TEE, ICE represents a purely intraprocedural guiding and imaging tool unsuitable for diagnostic purposes. Patients tolerate ICE much better, and the method does not require general anaesthesia. Accurate imaging of the particular pathology, its anatomic features, and spatial relation to the surrounding structures is critical for catheter and wire positioning, device deployment, evaluation of the result, and for ruling out complications. This review describes the peri-interventional role of ICE, outlines current limitations, and points out future implications. Two-dimensional ICE has become a suitable guiding tool for a variety of percutaneous treatments in patients who are conscious or under monitored anaesthesia care, whereas RT-3DICE is still undergoing clinical testing. Continuous TEE monitoring under general anaesthesia remains a widely accepted alternative.

S24216390 

The natriuretic peptides are important tools to establish diagnosis and prognosis in heart failure (HF). With application of therapies for HF, changes in both B-type natriuretic peptide (BNP) and its amino terminal cleavage fragment (NT-proBNP) parallel the benefits of the HF therapy applied. This dynamic nature of BNP and NT-proBNP relative to therapeutic intervention in HF has led to the concept of using the biomarkers as a 'guide' for intensification of HF care with a goal of not only achieving guideline-directed medical therapy goals accompanied by targeted natriuretic peptide suppression below prognostic thresholds. In studies achieving this combination of therapy optimization and BNP/NT-proBNP suppression, superior outcomes have been observed, and the approach was well tolerated. Natriuretic peptide-guided HF therapy has recently been given a recommendation in US HF guidelines to achieve guideline-directed medical therapy (Class IIa) and possibly improve outcome (Class IIb), while other clinical practice guidelines (including those from the European Society of Cardiology) await results from emerging clinical trial data. We will review lessons learned in the past regarding this novel concept of biomarker guided HF care, and discuss future directions for the approach.

 

FAMILY MEDICINE

 

S24415505  

Considerable variation in ethics education is apparent in both curricular content and delivery among family medicine residency programs in the United States. Additional findings included a lack of specification of explicit curricular aims for ethics teaching allied to ACGME or AAFP competencies, a tendency not to designate one faculty member with lead responsibility for ethics teaching in the residency program, and a lack of formal assessment of ethics competencies. This has occurred in the context of an absence of robust assessment of ethics competencies at board certification level.

S24415502  

Improving opportunities for primary care are evident in the evolving health care marketplace. Yet a secure and meaningfully scaled role in the future for family medicine and primary care is not assured. Family medicine can help lead the primary care movement now-from both clinical and policy perspectives-by energetically embracing newly emerging care options rather than becoming complacent or defensive. Avoiding complacency means: (1) improving assessment and intervention for social and health system complexity (our complex patients), (2) regarding primary care as a way of operating, not as a geographical place-even with the name medical home in place, (3) coordinating with dedicated mobile teams for our most complex and costly patients, and (4) improving leadership competence at a level required for transformation, not just maintenance.

 

GACETA SANITARIA

 

S24332818  

El consumo de tabaco en los adolescentes está disminuyendo desde hace algunos años en Barcelona. Hay una asociación muy intensa entre el consumo de tabaco y el de cannabis.

S23916983  

La cobertura del cribado cervical del sistema público de Cataluña incluye a una de cada tres mujeres. La participación en la segunda ronda fue baja. Los sistemas informáticos existentes en los centros de atención primaria son herramientas que pueden garantizar un seguimiento de la población, y además podrían ser útiles para planificar un cribado poblacional que asegure una buena cobertura y un buen seguimiento.

S23845269  

Sólo un 26% de las mujeres de Cantabria se realizan citologías con la periodicidad aconsejada en el protocolo oportunista vigente. Los datos de costes presentados en este trabajo pueden ser útiles para futuras evaluaciones económicas.

S23680136  

Hay diferencias en la prevalencia de morbilidad y en el consumo de fármacos según la fuente de información utilizada. Resulta aconsejable utilizar de manera complementaria diversas fuentes para estimar prevalencias reales en salud.

 

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

 

S24399554  

Among cigarette smokers, combined use of varenicline and bupropion, compared with varenicline alone, increased prolonged abstinence but not 7-day point prevalence at 12 and 26 weeks. Neither outcome was significantly different at 52 weeks. Further research is required to determine the role of combination therapy in smoking cessation.

S24381967  

Among patients with mild to moderate AD, 2000 IU/d of alpha tocopherol compared with placebo resulted in slower functional decline. There were no significant differences in the groups receiving memantine alone or memantine plus alpha tocopherol. These findings suggest benefit of alpha tocopherol in mild to moderate AD by slowing functional decline and decreasing caregiver burden.

S24231879  

Medications approved for long-term obesity treatment, when used as an adjunct to lifestyle intervention, lead to greater mean weight loss and an increased likelihood of achieving clinically meaningful 1-year weight loss relative to placebo. By discontinuing medication in patients who do not respond with weight loss of at least 5%, clinicians can decrease their patients' exposure to the risks and costs of drug treatment when there is little prospect of long-term benefit.

S24247483  

CAC volume was positively and independently associated with CHD and CVD risk. At any level of CAC volume, CAC density was inversely and significantly associated with CHD and CVD risk. The role of CAC density should be considered when evaluating current CAC scoring systems.

S24449318  

This study identified 2 diagnostic panels based on microRNA expression in whole blood with the potential to distinguish patients with pancreatic cancer from healthy controls. Further research is necessary to understand whether these have clinical implications for early detection of pancreatic cancer and how much this information adds to serum CA19-9.

S24399553  

Among smokers with serious mental illness who attained initial abstinence with standard treatment, maintenance pharmacotherapy with varenicline and cognitive behavioral therapy improved prolonged tobacco abstinence rates compared with cognitive behavioral therapy alone after 1 year of treatment and at 6 months after treatment discontinuation.

S24240611  

Among adults with out-of-hospital cardiac arrest, there was no significant difference in 4-hour survival between patients treated with the mechanical CPR algorithm or those treated with guideline-adherent manual CPR. The vast majority of survivors in both groups had good neurological outcomes by 6 months. In clinical practice, mechanical CPR using the presented algorithm did not result in improved effectiveness compared with manual CPR.

S24399558  

CLINICAL QUESTION:

Among the 3 first-line smoking cessation treatments (nicotine replacement therapy [NRT], bupropion, and varenicline), which is most effective in helping people who smoke achieve and maintain abstinence from smoking for at least 6 months, and what serious adverse events are associated with each?

BOTTOM LINE:

Higher rates of smoking cessation were associated with NRT (17.6%) and bupropion (19.1%) compared with placebo (10.6%). Varenicline (27.6%) and combination NRT (31.5%) (eg, patch plus inhaler) were most effective for achieving smoking cessation. None of the therapies was associated with an increased rate of serious adverse events

S24399557  

Since 1980, large reductions in the estimated prevalence of daily smoking were observed at the global level for both men and women, but because of population growth, the number of smokers increased significantly. As tobacco remains a threat to the health of the world's population, intensified efforts to control its use are needed.

S24430321  

Recent studies demonstrate a lesser role for aggressive antibiotic or surgical intervention for chronic or recurrent diverticulitis than was previously thought necessary.

S24399556  

Between 2004 and 2011, the decline in smoking among individuals with mental illness was significantly less than among those without mental illness, although quit rates were greater among those receiving mental health treatment. This suggests that tobacco control policies and cessation interventions targeting the general population have not worked as effectively for persons with mental illness.

S24399555  

Tobacco control was estimated to be associated with avoidance of 8 million premature deaths and an estimated extended mean life span of 19 to 20 years. Although tobacco control represents an important public health achievement, efforts must continue to reduce the effect of smoking on the nation's death toll.

 

JAMA INTERNAL MEDICINE

 

S24100714  

We observed a trend toward levothyroxine treatment of more marginal degrees of hypothyroidism and a substantial risk of developing a suppressed thyrotropin level following therapy. Large-scale prospective studies are required to assess the risk-benefit ratio of current practice.

S24190578  

Gabapentin (particularly the 1800-mg dosage) was effective in treating alcohol dependence and relapse-related symptoms of insomnia, dysphoria, and craving, with a favorable safety profile. Increased implementation of pharmacological treatment of alcohol dependence in primary care may be a major benefit of gabapentin as a treatment option for alcohol dependence.

S24217719  

These findings suggest that overweight and obesity are risk factors for MI and IHD regardless of the presence or absence of metabolic syndrome and that metabolic syndrome is no more valuable than BMI in identifying individuals at risk.

S24217806  

Overall and abdominal obesity were important and potentially modifiable factors associated with dying or developing mobility disability and major chronic disease before 85 years of age in older women.

S24100783  

Using the accelerated diagnostic protocol in the experimental pathway almost doubled the proportion of patients with chest pain discharged early. Clinicians could discharge approximately 1 of 5 patients with chest pain to outpatient follow-up monitoring in less than 6 hours. This diagnostic strategy could be easily replicated in other centers because no extra resources are required.

S24190540  

AF is independently associated with an increased risk of incident MI, especially in women and blacks. These findings add to the growing concerns of the seriousness of AF as a public health burden: in addition to being a well-known risk factor for stroke, AF is also associated with increased risk of MI.

S24190287  

For decades, stroke has been the principally recognized and most clinically relevant sequelae of atrial fibrillation (AF).1 However, a recent analysis demonstrated that AF may also lead to worsening renal function, a particularly important observation given that chronic kidney disease has been primarily considered a risk factor for the development of AF.2 While coronary artery disease and myocardial infarction (MI) have been demonstrated to increase AF risk,1 Soliman et al,3 in this issue of JAMA Internal Medicine, show that AF itself may also lead to an increased risk of incident MI. These data therefore add to the growing recognition of important bidirectional relationships between AF and other cardiovascular comorbidities. Just as “AF begets AF,”4 we are learning it may also lead to kidney disease, heart failure, and now MI. As we consider these new findings and their implications, we must first carefully examine the strengths and limitations of this recent study as well as the mechanisms through which these observed associations might occur.

 

JAMA PSYCHIATRY

 

S24227182  

The FMP was pivotal in the overall pattern of decreasing depressive symptoms in midlife women, with higher risk before and lower risk after the FMP. A history of depression strongly increased the risk both before and after menopause. Women who had no history of depression before the menopause transition had a low risk of depressive symptoms 2 or more years after the FMP.

 

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE

 

S24390880 

Today's US physician workforce principally comprises specialists trained in the care of specific chronic conditions in the outpatient setting. However, a majority of patients seeking care for most of 14 high-cost chronic conditions, for example hypertension, were more likely to see a primary care physician than a specialist physician (69% vs. 24%, respectively).

S24390887 

Providing patients with enhanced feedback did not dramatically change outcomes. However, across groups, many patients maintained or lost weight, suggesting the need for more study of nondiet interventions.

S24390876 

This issue's policy brief provides a good summary point for this issue: family physicians are complex care physicians (in addition to their other many roles). Another article demonstrates that family physicians provide more care during a preventive gynecologic visit than obstetrician-gynecologists. Completing the American Board of Family Medicine Maintenance of Certification modules are associated with higher quality of care. A learning collaborative shows the fruits of their effort to implement patient-centered medical homes. A new risk calculator for colorectal cancer is presented. Pregnant patients are more likely to accept the flu vaccine when presented by a physician rather than a nurse or medical assistant. We can "maladapt" to new information, such as not using aspirin for primary cardiac disease prevention or the low risk of lactic acidosis with metformin.

S24390895 

Convention holds that the use of metformin is contraindicated in many patients secondary to concerns about lactic acidosis. However, current evidence suggests that metformin-associated lactic acidosis is at most idiosyncratic. Awareness of the current evidence should permit broader use of this valuable medication.

 

MEDICINA CLINICA

 

S23332628  

Existe una alta variabilidad en las recomendaciones de las guías y otros documentos para el abordaje clínico de la osteoporosis.

S23768852  

Se observan variaciones clínicas significativas durante dicho período de tiempo de 19 años, con un incremento en la edad de presentación, en la frecuencia de fibrilación auricular y EPOC y en el uso de la RM cerebral. La HIC constituye un subtipo de ictus grave con una mayor mortalidad precoz y una menor frecuencia de ausencia de sintomatología al alta hospitalaria en comparación con los infartos cerebrales.

S23337454  

Los pacientes que inician un tratamiento sustitutivo de la heroína son cada vez de mayor edad y muestran mayor frecuencia de comorbilidad psiquiátrica. Sin embargo, se demuestra un marcado descenso de las infecciones por el VIH y las hepatitis.

S24216011  

La presente revisión pretende ofrecer un enfoque práctico de cómo redactar un informe para la evaluación de minusvalía o discapacidad. Para ello, previamente revisaremos de manera breve los tipos de ayuda por minusvalía o discapacidad y los procesos administrativos y judiciales para su evaluación y concesión.

S23433666  

Existe variabilidad en las políticas de prevención cardiovascular entre las CCAA. Convendría extender la implantación de una guía consensuada de prevención cardiovascular, la valoración del RCV en la historia clínica electrónica, haciendo especial énfasis en los estilos de vida, y la incorporación de la valoración y control del RCV entre los indicadores de calidad asistencial y los sistemas de incentivación profesional.

 

REVISTA ESPAÑOLA DE CARDIOLOGIA

 

S24231045  

Hay diferencias clínicas y demográficas entre varones y mujeres que ingresan por un primer infarto de miocardio. El pronóstico a corto plazo es similar en ambos sexos. La mortalidad a 7 años de un primer infarto de miocardio es peor en varones que en mujeres. Estos resultados se observan en infartos agudos de miocardio con y sin elevación del segmento ST.

 

THE LANCET

 

S24139977  

This form of adapted cognitive behaviour therapy for health anxiety led to sustained symptomatic benefit over 2 years, with no significant effect on total costs. It deserves wider application in medical care.

S24119980  

Continuing widespread use of vitamin D for osteoporosis prevention in community-dwelling adults without specific risk factors for vitamin D deficiency seems to be inappropriate.

S24449944  

Although age-standardised rates of stroke mortality have decreased worldwide in the past two decades,the absolute number of people who have a stroke every year, stroke survivors, related deaths, and the overall global burden of stroke (DALYs lost) are great and increasing. Further study is needed to improve understanding of stroke determinants and burden worldwide, and to establish causes of disparities and changes in trends in stroke burden between countries of different income levels.

 

THE NEW ENGLAND JOURNAL OF MEDICINE

 

S24428469  

We observed a J-shaped association between BMI and mortality among all participants and among those who had ever smoked and a direct linear relationship among those who had never smoked. We found no evidence of lower mortality among patients with diabetes who were overweight or obese at diagnosis, as compared with their normal-weight counterparts, or of an obesity paradox.

S24382065  

The risk of a crash or near-crash among novice drivers increased with the performance of many secondary tasks, including texting and dialing cell phones.

 

THORAX

 

S23908128 

We observed a novel association of lower plasma 25(OH)D levels with faster decline in lung function and with a higher risk of COPD in prospective analyses.

S23704227 

It is characteristic of asthma that symptoms worsen overnight, particularly in the early hours of the morning. Nocturnal symptoms in asthma are common and are an important indicator for escalation of treatment. An extensive body of research has demonstrated that nocturnal symptoms of cough and dyspnea are accompanied by circadian variations in airway inflammation and physiologic variables, including airflow limitation and airways hyper-responsiveness. The molecular apparatus that underpins circadian variations, controlled by so called 'clock' genes, has recently been characterised. Clock genes control circadian rhythms both centrally, in the suprachiasmatic nucleus of the brain and peripherally, within every organ of the body. Here, we will discuss how clock genes regulate circadian rhythms. We will focus particularly on the peripheral lung clock and the peripheral immune clock and discuss how these might relate to both the pathogenesis and treatment of asthma.

 

                      

 

3as JJ Eco 


____________________________

 Para pacientes
@pontealdiaAP
 @pontealdiaURG
55 e.SAMFyC

 


 

semFYC
 

 

Estadisticas

Ver contenido por hits : 1150500



La SAMFyC:
 C/ Arriola, 4, bajo D, CP.18001 - Granada. Email: samfyc@samfyc.es; Teléfono: 958 804 201 - Fax: 958 804 202. Horario de invierno: lunes a jueves de 9:00 a 17:30 horas; viernes de 9:00 a 14:30 horas. Horario de verano: lunes a viernes de 8:00 a 15:00h. Todos los derechos reservados. Aviso Legal. 


¡CSS Válido!

Diseño web